Skip to main content
. 2019 Dec 2;42(6):186–191. doi: 10.18773/austprescr.2019.067
Severe renal impairment:
  • CrCl <30 mL/min with dabigatran

  • CrCl <15 mL/min with apixaban*

  • CrCl <15 mL/min with rivaroxaban*

Liver impairment e.g. cirrhosis (Child Pugh C)
Current active bleeding or coagulopathy
Previous life-threatening haemorrhage while on a direct oral anticoagulant
Documented previous anaphylaxis to a direct oral anticoagulant
* International European guidelines approve the use of apixaban and rivaroxaban in patients with CrCl as low as 15 mL/min, however this is not reflected in Australian guidance (see Table 3).
CrCl creatinine clearance
Source: reference 18